Price to Book Value Chart

View Price to Book Value for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
September 18, 2026 1.365
September 17, 2026 1.326
September 16, 2026 1.347
September 15, 2026 1.295
September 14, 2026 1.369
September 11, 2026 1.317
September 10, 2026 1.313
September 09, 2026 1.339
September 08, 2026 1.391
September 04, 2026 1.43
September 03, 2026 1.404
September 02, 2026 1.395
September 01, 2026 1.408
August 31, 2026 1.365
August 28, 2026 1.33
August 27, 2026 1.33
August 26, 2026 1.334
August 25, 2026 1.321
August 24, 2026 1.278
August 21, 2026 1.321
August 20, 2026 1.291
August 19, 2026 1.352
August 18, 2026 1.300
August 17, 2026 1.274
August 14, 2026 1.304
Date Value
August 13, 2026 1.252
August 12, 2026 1.248
August 11, 2026 1.252
August 10, 2026 1.274
August 07, 2026 1.326
August 06, 2026 1.356
August 05, 2026 1.369
August 04, 2026 1.408
August 03, 2026 1.395
July 31, 2026 1.421
July 30, 2026 1.413
July 29, 2026 1.452
July 28, 2026 1.452
July 27, 2026 1.347
July 24, 2026 1.352
July 23, 2026 1.369
July 22, 2026 1.474
July 21, 2026 1.556
July 20, 2026 1.513
July 17, 2026 1.495
July 16, 2026 1.547
July 15, 2026 1.547
July 14, 2026 1.486
July 13, 2026 1.569
July 10, 2026 1.560

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.929
Corcept Therapeutics, Inc. 16.86
Veru, Inc. 1.448
Johnson & Johnson 7.652
Eli Lilly & Co. 32.04

Price to Book Value Related Metrics

PS Ratio 4.195
Price 3.14
Earnings Yield -1.26%
Market Cap 225.59M